Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) VP Jeff Fairman sold 4,112 shares of Vaxcyte stock in a transaction on Friday, May 20th. The stock was sold at an average price of $25.50, for a total transaction of $104,856.00. Following the transaction, the vice president now directly owns 321,227 shares in the company, valued at $8,191,288.50. […]
Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating) VP Jeff Fairman sold 5,000 shares of the business’s stock in a transaction on Tuesday, April 5th. The shares were sold at an average price of $25.59, for a total value of $127,950.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is […]
Vaxcyte, Inc. (NASDAQ:PCVX – Get Rating)’s stock price gapped up before the market opened on Thursday . The stock had previously closed at $25.68, but opened at $26.55. Vaxcyte shares last traded at $26.38, with a volume of 1,109 shares traded. Several research firms have recently commented on PCVX. Zacks Investment Research downgraded shares of […]